comparemela.com

Latest Breaking News On - ஜான்சன் இந்தியா - Page 1 : comparemela.com

J&J vaccine: Johnson & Johnson seeks nod for trial of single-dose vaccine on adolescents in India

Johnson & Johnson seeks regulator nod for vax trials in 12-17 age group in India

The American-based pharma major Johnson & Johnson (J&J) has applied to the Central Drugs Standard Control Organisation (CDSCO) for permission to conduct a vaccine trial of the Covid-19 single shot Janssen vaccine in India on children of .

United-states
India
New-delhi
Delhi
American
Mansukh-mandaviya
Johnson
Serum-institute-covishield
Union-health
Central-drugs-standard-control-organisation
Emergency-use-authorisation
Drug-controller-general

Johnson & Johnson seeks nod for trial of single-dose vaccine on adolescents in India

Johnson & Johnson sought approval for a trial on children aged 12 to 17 in India | જોનસન એન્ડ જોનસને ભારતમાં 12થી 17 વર્ષનાં બાળકો પર ટ્રાયલ માટે મંજૂરી માગી

Johnson & Johnson sought approval for a trial on children aged 12 to 17 in India | જોનસન એન્ડ જોનસને ભારતમાં 12થી 17 વર્ષનાં બાળકો પર ટ્રાયલ માટે મંજૂરી માગી
divyabhaskar.co.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from divyabhaskar.co.in Daily Mail and Mail on Sunday newspapers.

India
Johnson-india
American-pharma
Central-drugs
Drugs-general
இந்தியா
ஜான்சன்-இந்தியா
அமெரிக்கன்-பார்மா
மைய-மருந்துகள்

Johnson & Johnson seeks regulator nod for single-dose Covid vaccine trials on 12-17 age group in India

COVID-19,Coronavirus,COVID-19 vaccine,Johnson Johnson, Johnson and Johnson, Johnson and Johnson vaccine, india, Johnson and Johnson trials in india,coronavirus,India,health,vaccine,coronavirus vaccine,COVID-19 vaccine,Johnson & Johnson,Janssen,SII,Covishield,Bharat Biotech,Covaxin,Sputnik V,Moderna

United-states
India
American
Mansukh-mandaviya
Johnson
Serum-institute-covishield
Union-health
Central-drugs-standard-control-organisation
Image-source
Emergency-use-authorisation
Drug-controller-general
Johnson-india

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.